ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,000 | -92.1% | 1,043 | -83.7% | 0.00% | -100.0% |
| Q4 2019 | $38,000 | -29.6% | 6,395 | -38.8% | 0.00% | -50.0% |
| Q3 2019 | $54,000 | +800.0% | 10,448 | +989.5% | 0.00% | – |
| Q2 2019 | $6,000 | -92.9% | 959 | -89.7% | 0.00% | -100.0% |
| Q1 2019 | $84,000 | +13.5% | 9,285 | +4.5% | 0.01% | 0.0% |
| Q4 2018 | $74,000 | +32.1% | 8,888 | +118.6% | 0.01% | +75.0% |
| Q3 2018 | $56,000 | – | 4,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |